You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Drugs Containing Excipient (Inactive Ingredient) CALCIUM PHOSPHATE, MONOBASIC, ANHYDROUS


✉ Email this page to a colleague

« Back to Dashboard


Generic drugs containing CALCIUM PHOSPHATE, MONOBASIC, ANHYDROUS excipient

CALCIUM PHOSPHATE, MONOBASIC, ANHYDROUS Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Calcium Phosphate, Monobasic, Anhydrous

Introduction

Calcium phosphate, monobasic, anhydrous, is a crucial component in various industries, including pharmaceuticals, animal feed, food and beverage, and agriculture. This article delves into the market dynamics and financial trajectory of this pharmaceutical excipient, highlighting key trends, drivers, restraints, and future projections.

Market Size and Growth Projections

The global anhydrous dibasic calcium phosphate market, closely related to monobasic calcium phosphate, is expected to exhibit significant growth. As of 2022, the market was valued at US$ 213.5 million and is projected to reach US$ 315.1 million by 2030, recording a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast period (2023-2030)[5].

Drivers of Market Growth

Several factors are driving the growth of the calcium phosphate market:

Health Awareness and Dietary Supplements

The increasing health awareness and growing consumption of dietary supplements are major drivers. Phosphorus, a key component of calcium phosphate, is essential for various bodily functions, making it a popular ingredient in health supplements[1].

Pharmaceutical Industry

The pharmaceutical sector, particularly the production of generic drugs and innovative medications, is another significant driver. Calcium phosphate is used as an excipient in many pharmaceutical formulations due to its stability and bioavailability[3].

Animal Feed and Agriculture

The demand from the animal feed and agriculture sectors also contributes to market growth. Calcium phosphate is used in poultry feed and as a fertilizer, enhancing crop yields and animal health[2].

Regional Market Dynamics

North America

North America is expected to account for a significant market share due to improving product qualities and evolving regulations. The presence of prominent pharmaceutical companies in this region, such as Roche, Merck & Co., and Pfizer, further boosts the demand for calcium phosphate[4].

Asia-Pacific

The Asia-Pacific region is anticipated to dominate the market in the coming years, driven by increasing manufacturing activities and a growing food and beverage industry. This region's developing agriculture sector also contributes to the rising demand for calcium phosphate[5].

Europe

Europe, with its sizable healthcare sector and significant geriatric population, also plays a crucial role in the market. The elderly population's increasing demand for health supplements and pharmaceuticals drives the growth of the calcium phosphate market[4].

Restraints and Challenges

Despite the positive growth trajectory, several challenges hinder the market:

High Costs

The high costs associated with the production of anhydrous dibasic calcium phosphate, particularly the increased prices of phosphoric acid and calcium oxide, are significant restraints. These costs have risen nearly 30% since the start of 2022, driven by surging input costs, supply disruptions, and export restrictions[5].

Regulatory Constraints

Strict regulations on the use of dibasic calcium phosphate in various applications can also hamper market growth. Compliance with these regulations adds to the operational costs and complexity for manufacturers[1].

Key Players and Market Strategies

Several key players are actively involved in the global anhydrous dibasic calcium phosphate market:

Mergers and Acquisitions

Companies like the Mosaic Company have expanded their production capacities through acquisitions, such as the purchase of Vale Fertilizantes, to strengthen their market positions[1].

Research and Development

Collaborative agreements, such as the one between EuroChem Group and Aphea.Bio, focus on the R&D of next-generation fertilizer technologies, which helps in enhancing market positions and driving innovation[1].

Product Diversification

Companies like Innophos, Phosphea, and Sudeep Pharma are diversifying their product portfolios to cater to various end-use industries, thereby mitigating risks and capitalizing on emerging opportunities[2].

Market Segmentation

The market is segmented based on type and application:

By Type

  • Hydrochloric Acid
  • Phosphoric Acid

By Application

  • Animal Feed
  • Food & Beverage
  • Agriculture
  • Pharmaceutical
  • Others

Understanding these segments helps in identifying specific market opportunities and challenges[2].

Future Outlook

The future of the calcium phosphate market looks promising, driven by several factors:

Increasing Geriatric Population

The rising geriatric population is expected to increase the demand for food supplements and pharmaceuticals, thereby driving the market growth. By 2030, 1 in 6 people in the world will be aged 60 years or over, according to the World Health Organization[5].

Government Initiatives and Healthcare Expenditure

Government initiatives to improve healthcare infrastructure and the escalating healthcare expenditure are expected to propel the market growth. The focus on sustainable packaging, mergers and acquisitions, and the use of artificial intelligence in supply chains will also play a significant role[3].

Economic and Social Landscapes

The economic, political, and social landscapes of countries, particularly in emerging markets, will influence the market dynamics. Robust economic development and the establishment of advanced healthcare infrastructure will drive the demand for calcium phosphate[3].

Key Takeaways

  • The global anhydrous dibasic calcium phosphate market is projected to grow at a CAGR of 5.7% from 2023 to 2030.
  • Health awareness, dietary supplements, and the pharmaceutical industry are key drivers of market growth.
  • North America and Asia-Pacific are expected to be dominant regions in the market.
  • High costs and regulatory constraints are significant restraints.
  • Key players are focusing on R&D, mergers and acquisitions, and product diversification.

FAQs

What is the projected CAGR for the global anhydrous dibasic calcium phosphate market from 2023 to 2030?

The global anhydrous dibasic calcium phosphate market is expected to exhibit a CAGR of 5.7% during the forecast period (2023-2030)[5].

Which regions are expected to dominate the calcium phosphate market?

North America and Asia-Pacific are anticipated to be the dominant regions in the calcium phosphate market, driven by various industrial and demographic factors[4][5].

What are the main applications of calcium phosphate?

Calcium phosphate is used in animal feed, food and beverage, agriculture, pharmaceuticals, and other industries[2].

How does the rising geriatric population impact the market?

The increasing geriatric population drives the demand for health supplements and pharmaceuticals, thereby boosting the market growth for calcium phosphate[5].

What are the key restraints in the calcium phosphate market?

High production costs and strict regulatory constraints are the significant restraints in the market[1][5].

Sources

  1. Coherent Market Insights - Global Anhydrous Dibasic Calcium Phosphate Market to Surpass US$ 254.7 Million by 2027[1].
  2. Market Research Intellect - Global Anhydrous Dibasic Calcium Phosphate Market Size, Scope[2].
  3. Research and Markets - Pharmaceutical Excipients Global Market Report 2024[3].
  4. Straits Research - Calcium Phosphate Market Size, Share, Growth, Demand Forecast[4].
  5. Coherent Market Insights - Anhydrous Dibasic Calcium Phosphate Market Size & Share Analysis[5].

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.